Updated results of ALTER-C002: Anlotinib combined with CAPEOX in first-line treatment of patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer.
文献类型：期刊论文
| 作者 | Ding, Ke-Feng; Liu, Yue; Du, Jinlin; Zhu, Yuping; Liu, Zhuo; Wang, Jianping; Xu, Dong; Li, Jun; Liao, Xiujun; Sun, Lifeng |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2021-05-20 |
| 卷号 | 39 |
| ISSN号 | 0732-183X |
| DOI | 10.1200/JCO.2021.39.15_suppl.e15564 |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000708120301229 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/126656]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Zhejiang Univ, Dept Colorectal Surg & Oncol, Key Lab Canc Prevent & Intervent, Minist Educ,Affiliated Hosp 2, Hangzhou, Peoples R China 2.Zhejiang Univ, Jinhua Hosp, Colorectal Surg, Jinhua, Zhejiang, Peoples R China 3.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Colorectal Surg, Canc Hosp, Hangzhou, Peoples R China 4.Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China |
| 推荐引用方式 GB/T 7714 | Ding, Ke-Feng,Liu, Yue,Du, Jinlin,et al. Updated results of ALTER-C002: Anlotinib combined with CAPEOX in first-line treatment of patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
| APA | Ding, Ke-Feng.,Liu, Yue.,Du, Jinlin.,Zhu, Yuping.,Liu, Zhuo.,...&Yuan, Ying.(2021).Updated results of ALTER-C002: Anlotinib combined with CAPEOX in first-line treatment of patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer..JOURNAL OF CLINICAL ONCOLOGY,39. |
| MLA | Ding, Ke-Feng,et al."Updated results of ALTER-C002: Anlotinib combined with CAPEOX in first-line treatment of patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer.".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。